• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator.

作者信息

Prewitt R M, Gu S, Garber P J, Ducas J

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

J Am Coll Cardiol. 1992 Dec;20(7):1626-33. doi: 10.1016/0735-1097(92)90459-z.

DOI:10.1016/0735-1097(92)90459-z
PMID:1452937
Abstract

OBJECTIVES

This study was designed to test the hypothesis that the level of aortic blood pressure affects the rate and extent of coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator (rt-PA).

BACKGROUND

Although many studies have confirmed the efficacy of thrombolytic therapy in the treatment of acute myocardial infarction, the effects of altered blood pressure on coronary thrombolysis have not been studied. Because the aortic pressure represents the coronary artery inflow pressure, first principles predict that changes in blood pressure will affect the delivery of the thrombolytic agent and thus affect thrombolysis.

METHODS

The effects of large changes in blood pressure on coronary thrombolysis were studied in a canine model. Coronary thrombosis was induced by injection of radioactive blood clot through a catheter placed in the left anterior descending coronary artery. Subsequently, 24 dogs were classified into three groups of 8 dogs each: Group 1 dogs underwent phlebotomy to adjust systolic blood pressure to 130 mm Hg; Group 2 dogs underwent phlebotomy to decrease systolic blood pressure to 75 mm Hg. Dogs in Group 3 also underwent phlebotomy to achieve a systolic blood pressure of 75 mm Hg and then received norepinephrine to increase this pressure to 130 mm Hg. After adjustment in blood pressure, all dogs received an infusion of rt-PA (0.25 mg/kg body weight) over 30 min through the left anterior descending artery catheter. In a fourth group of six dogs, the effect of altered blood pressure on the rate of coronary thrombolysis was assessed.

RESULTS

In dogs in Groups 1 and 3, the rate and extent of coronary thrombolysis were significantly increased compared with values in Group 2. In each of the six Group 4 dogs the rate of coronary thrombolysis increased when norepinephrine increased systolic blood pressure from 75 to 130 mm Hg.

CONCLUSIONS

These results indicate that a moderate increase in coronary inflow pressure increases the rate and extent of coronary thrombolysis compared with values during marked systemic hypotension.

摘要

相似文献

1
Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator.
J Am Coll Cardiol. 1992 Dec;20(7):1626-33. doi: 10.1016/0735-1097(92)90459-z.
2
Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.
J Am Coll Cardiol. 1994 Mar 1;23(3):794-8. doi: 10.1016/0735-1097(94)90770-6.
3
An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator.
J Crit Care. 1995 Mar;10(1):1-6. doi: 10.1016/0883-9441(95)90024-1.
4
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration.重组组织型纤溶酶原激活剂冠状动脉溶栓治疗。冠状动脉内给药与静脉内给药对比。
Chest. 1991 Jul;100(1):201-6. doi: 10.1378/chest.100.1.201.
5
Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.重组组织型纤溶酶原激活剂的静脉给药。优化冠状动脉溶栓速率。
Chest. 1995 Apr;107(4):1146-51. doi: 10.1378/chest.107.4.1146.
6
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.冠状动脉溶栓。冠状动脉内注射重组组织型纤溶酶原激活剂与尿激酶的比较效果。
Chest. 1992 Jun;101(6):1684-90. doi: 10.1378/chest.101.6.1684.
7
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.硝酸甘油联合治疗未能提高组织型纤溶酶原激活剂对冠状动脉血栓形成疗效的病理基础。
Cardiovasc Res. 1991 Apr;25(4):283-9. doi: 10.1093/cvr/25.4.283.
8
Effect of a mechanical vs a pharmacologic increase in aortic pressure on coronary blood flow and thrombolysis induced by IV administration of a thrombolytic agent.
Chest. 1997 Feb;111(2):449-53. doi: 10.1378/chest.111.2.449.
9
Effect of rate of administration of recombinant tissue plasminogen activator on efficacy of coronary thrombolysis.重组组织型纤溶酶原激活剂给药速率对冠状动脉溶栓疗效的影响。
Angiology. 1994 Aug;45(8):687-94. doi: 10.1177/000331979404500803.
10
Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.氧自由基清除剂在犬冠状动脉溶栓模型中作为组织型纤溶酶原激活剂辅助治疗的研究
Cardiovasc Res. 1993 Jun;27(6):925-34. doi: 10.1093/cvr/27.6.925.

引用本文的文献

1
Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter study.急性 ST 段抬高型心肌梗死患者入院血压与自发性再灌注及长期预后的关系:一项观察性多中心研究。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):500. doi: 10.1186/s12872-024-04168-4.
2
Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors.磁驱动纳米马达加速组织纤溶酶原激活剂介导的溶栓作用
ACS Nano. 2014 Aug 26;8(8):7746-54. doi: 10.1021/nn5029955. Epub 2014 Jul 15.
3
Association Between Serial Measures of Systemic Blood Pressure and Early Coronary Arterial Perfusion Status Following Intravenous Thrombolytic Therapy.
静脉溶栓治疗后系统性血压的系列测量与早期冠状动脉灌注状态之间的关联
J Thromb Thrombolysis. 1994;1(1):79-84. doi: 10.1007/BF01062000.
4
Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.早期加速剂量组织型纤溶酶原激活剂对急性右心室梗死患者梗死血管院内通畅率的影响
Heart. 1997 Jun;77(6):512-6. doi: 10.1136/hrt.77.6.512.